Beijing Leadman Biochemistry Co.,Ltd. (300289.SZ)
CNY 5.52
(-0.18%)
CNY 5.52
(-0.18%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 23.9 Million CNY | 169.17% |
| 2022 | 7.56 Million CNY | -87.44% |
| 2021 | 60.18 Million CNY | 872.79% |
| 2020 | -7.78 Million CNY | -124.8% |
| 2019 | 31.39 Million CNY | -56.86% |
| 2018 | 72.79 Million CNY | -37.86% |
| 2017 | 117.14 Million CNY | 22.5% |
| 2016 | 95.63 Million CNY | -51.83% |
| 2015 | 198.5 Million CNY | 22.73% |
| 2014 | 161.74 Million CNY | 29.12% |
| 2013 | 125.26 Million CNY | 12.8% |
| 2012 | 111.04 Million CNY | 33.55% |
| 2011 | 83.15 Million CNY | 34.34% |
| 2010 | 61.89 Million CNY | 29.5% |
| 2009 | 47.79 Million CNY | 38.32% |
| 2008 | 34.55 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q2 | -409.48 Thousand CNY | 91.12% |
| 2024 Q3 | 1.84 Million CNY | 551.02% |
| 2024 Q1 | -4.61 Million CNY | -29.14% |
| 2023 Q1 | 12.23 Million CNY | 122.35% |
| 2023 Q4 | -3.57 Million CNY | -127.54% |
| 2023 FY | 20.35 Million CNY | 169.17% |
| 2023 Q3 | 12.96 Million CNY | 7.69% |
| 2023 Q2 | 12.04 Million CNY | -1.53% |
| 2022 FY | 7.56 Million CNY | -87.44% |
| 2022 Q3 | 17.32 Million CNY | -21.43% |
| 2022 Q4 | -54.71 Million CNY | -415.88% |
| 2022 Q1 | 22.9 Million CNY | 1430.15% |
| 2022 Q2 | 22.04 Million CNY | -3.76% |
| 2021 Q4 | -1.72 Million CNY | -105.53% |
| 2021 Q1 | 13.29 Million CNY | 128.69% |
| 2021 Q2 | 17.45 Million CNY | 31.31% |
| 2021 Q3 | 31.15 Million CNY | 78.43% |
| 2021 FY | 60.18 Million CNY | 872.79% |
| 2020 FY | -7.78 Million CNY | -124.8% |
| 2020 Q4 | -46.34 Million CNY | -275.41% |
| 2020 Q3 | 26.42 Million CNY | 6.51% |
| 2020 Q2 | 24.8 Million CNY | 295.79% |
| 2020 Q1 | -12.66 Million CNY | -7643.61% |
| 2019 FY | 31.39 Million CNY | -56.86% |
| 2019 Q4 | -163.61 Thousand CNY | -101.47% |
| 2019 Q3 | 11.11 Million CNY | 24.85% |
| 2019 Q2 | 8.89 Million CNY | -22.96% |
| 2019 Q1 | 11.55 Million CNY | 154.5% |
| 2018 Q2 | 30.44 Million CNY | 6.2% |
| 2018 Q1 | 28.66 Million CNY | -11.04% |
| 2018 Q3 | 34.88 Million CNY | 14.59% |
| 2018 FY | 72.79 Million CNY | -37.86% |
| 2018 Q4 | -21.19 Million CNY | -160.77% |
| 2017 Q2 | 36.92 Million CNY | 74.6% |
| 2017 Q4 | 32.22 Million CNY | 20.01% |
| 2017 FY | 117.14 Million CNY | 22.5% |
| 2017 Q1 | 21.14 Million CNY | -29.79% |
| 2017 Q3 | 26.85 Million CNY | -27.29% |
| 2016 Q2 | 24.96 Million CNY | -0.14% |
| 2016 Q3 | 15.55 Million CNY | -37.69% |
| 2016 Q4 | 30.12 Million CNY | 93.67% |
| 2016 FY | 95.63 Million CNY | -51.83% |
| 2016 Q1 | 24.99 Million CNY | -70.72% |
| 2015 Q2 | 50.48 Million CNY | 131.08% |
| 2015 Q4 | 85.38 Million CNY | 109.29% |
| 2015 FY | 198.5 Million CNY | 22.73% |
| 2015 Q3 | 40.79 Million CNY | -19.19% |
| 2015 Q1 | 21.84 Million CNY | -73.89% |
| 2014 FY | 161.74 Million CNY | 29.12% |
| 2014 Q4 | 83.66 Million CNY | 209.09% |
| 2014 Q3 | 27.06 Million CNY | -25.92% |
| 2014 Q2 | 36.53 Million CNY | 152.41% |
| 2014 Q1 | 14.47 Million CNY | 7.63% |
| 2013 Q3 | 37.64 Million CNY | -17.0% |
| 2013 FY | 125.26 Million CNY | 12.8% |
| 2013 Q2 | 45.36 Million CNY | 57.47% |
| 2013 Q4 | 13.45 Million CNY | -64.27% |
| 2013 Q1 | 28.8 Million CNY | 0.98% |
| 2012 Q1 | 20.89 Million CNY | -3.03% |
| 2012 Q2 | 33.36 Million CNY | 59.71% |
| 2012 FY | 111.04 Million CNY | 33.55% |
| 2012 Q3 | 28.26 Million CNY | -15.28% |
| 2012 Q4 | 28.52 Million CNY | 0.92% |
| 2011 Q1 | 15.35 Million CNY | 0.0% |
| 2011 Q3 | 22.12 Million CNY | -8.29% |
| 2011 Q2 | 24.12 Million CNY | 57.12% |
| 2011 FY | 83.15 Million CNY | 34.34% |
| 2011 Q4 | 21.54 Million CNY | -2.64% |
| 2010 FY | 61.89 Million CNY | 29.5% |
| 2009 FY | 47.79 Million CNY | 38.32% |
| 2008 FY | 34.55 Million CNY | 0.0% |